Tag Archives: Acute coronary syndrome

weight loss

Coronary heart problems and diabetes

Coronary heart problems

Coronary heart problems and diabetes are not just problems for the elderly

Coronary heart problems and diabetes: The known effects

Diabetes plays a major role in causing coronary heart problems. With this, diabetes patients are more likely to develop coronary heart disease than diabetes-free people. The relationship between diabetes and coronary heart problems is important for all patients. This will enable them to take the most appropriate action in keeping healthy. And just for further illustration, from the various studies, experts have established that established that diabetes causes high levels of glucose in the blood and when this happens, it impacts negatively on the walls of the arteries causing them to develop fatty deposits commonly known as atheroma. If this atheroma is allowed to build up in the coronary arteries (the arteries that supply oxygen-rich blood to your heart) the individual patient affected is likely to develop coronary heart disease which can eventually cause heart attack and angina says doctor Dalal Akoury MD and founder of AWAREmed Health and Wellness Resource Center. Now let us try to understand diabetes better in the context of causing coronary heart disease.

Coronary heart problems and diabetes: Types of diabetes

We have two common types of diabetes namely: Type 1 diabetes and Type 2 diabetes

Type 1 diabetes happens when the body lacks the capacity to produce insulin. This type common with the children and young adults. Type 2 diabetes occurs when your body can’t produce enough insulin or the insulin doesn’t work properly. Type 2 diabetes is more common and tends to develop gradually as people get older usually after the age of 40. This type of diabetes is closely associated with being overweight, being physically inactive and having a family history of diabetes. Like most people in the south Asia origin and the African, the Caribbean are associated with higher rates of diabetes. Nonetheless, when diabetes is present, the most important thing is how to eliminate it and reduce the risk of other complications that come with it. Therefore you can effectively reduce your risk of developing diabetes by controlling your weight and doing regular physical activity.

The great news is that doing these things will also make you less likely to develop other cardiovascular diseases such as coronary heart complications/disease and stroke as well as being great for your general mental and physical well-being. Whenever we mention engagement in physical activities many people do wonder how and whether they will achieve their set objectives. If this describes you then you need not worry for you are not alone. The most important thing to do is to resolve to take the first step of acknowledgment and willingness to lose. When this is done you can now seek for a more professional help from doctor Dalal Akoury MD who will take you through the best and natural weight loses exercises in the most professional way that will leave you much healthier. Remember that by losing weight and being active, you will be succeeding in solving several health complications as already mention.

Coronary heart problems and diabetes: The known effects





Clinical Trials For Heart Failure

What’s Heart Failure?

Heart failure is an intricate clinical condition of symptoms and signs that suggest malfunction of the heart. This is often caused by structural and or functional defects of the heart. A good number of patients have heart failures as a result of left ventricular systolic dysfunction (LVSD).

“More often than not, LVSD is associated with reduced left ventricular blood ejection fraction. Some patients have heart failure as a result of a preserved ejection fraction (HFPEF). Whereas the most popular cause of heart failure in the United States (US) is coronary artery disease, many patients have had a myocardial infarction,” Owan TE, Hodge D.O., Herges R.M, et al. (2006).

Heart failure and or related diseases often increase steadily with age, a typical age at first diagnosis being at 76 years. Prevalence of heart failure is even expected to rise in the near future as a result of an increased ageing population. Improved survival of people with heart disease and more effective treatments of the same are more reasons for such increased prevalence.

“Heart failure has a poor prognosis: 30–40% of persons diagnosed with the condition die within a year, after which the mortality rate is less than 10% for every succeeding year. However, there has been better prognosis in the past 10 years. The 6-month mortality rate further decreased from 26% in 1995 to 14% in 2005 and even further now,” Petersen S, Rayner M, and Wolstenholme J. (2002).

“Heart failure accounts for over a million inpatient bed-days 2% of all NHS inpatient bed-days in the US and 5% of all emergency medical admissions to hospital. The admissions because of the heart condition are even projected to rise by 50% over the next two decades, largely as a result of the ageing population,” Hobbs FD, Roalfe AK, and Davis R.C., et al. (2007).

This article provides acceptable and standard practices on adults with heart failures, especially those with chronic heart failures. Such trials entail diagnosis, treatment, and rehabilitation.

Heart Failure

Clinical Trials For Heart Failure

Clinical trials as well as therapeutic care should take into account the patients’ needs and preferences. A patient with acute heart failure for instance should be able to make or rather should be given an opportunity to make an informed decision about his/her therapeutic care together with the healthcare professionals.

If the patient does not have the ability to make reliable decision about his/her the trials and or therapeutic care, the healthcare professional should follow established guidelines set by the Department of Health on consent and the professional code of practice as set out in the Mental Capacity Act.

Also important is good communication between the patient and the professional. These may be in different forms but a recommended practice involves a written document that suits the patient’s unique clinic diagnosis and can also act as evidence. Clinical trials and therapeutic care given and information communicated to the patients should be appropriate to the latter’s medical history and culture.

Such information should be accessible to people with special needs such as physical, sensory, learning disabilities, and or to those who neither speak nor read English. Family members, guardians and or care-takers should also have an opportunity to contribute in the decisions about the trials and care.

“During clinical examinations, it is important to refer patients with supposed heart failures and or previous myocardial infarction (MI) urgently to have transthoracic Doppler 2D echocardiography and specialist assessment within 2 weeks,” Owan TE, Hodge D.O., Herges R.M, et al. (2006).

“Clinical trials on treatment should measure serum natriuretic peptides (B-type natriuretic peptide [BNP] or N-terminal pro-B type natriuretic peptide [NTproBNP]) in patients with suspected heart failure without previous MI. Because very high levels of serum natriuretic peptides carry a poor prognosis, refer patients with suspected heart failure and a BNP level above 400 pg/ml (116 pmol/litre) or an NTproBNP level above 2000 pg/ml (236 pmol/litre) urgently, to have the 2D echocardiography and assessment within 2 weeks,” Owan TE, Hodge D.O., Herges R.M, et al. (2006).

Heart Failure

Trials on treatment involve offering both angiotensin-converting enzyme (ACE) inhibitors and beta-blockers licensed for heart failure to all patients with heart failure due to left ventricular systolic dysfunction. It is also advisable to use clinical judgments when deciding which drug to use first.

Offer only beta-blockers licensed for heart failure to all patients with the heart condition due to left ventricular systolic dysfunction, including: adults and those patients with other vascular diseases, erectile dysfunction, diabetes mellitus, interstitial pulmonary disease, and or chronic obstructive pulmonary disease (COPD) without reversibility.

Professionals are also advised to seek specialist guidance to offer one of the following alternatives if the patient fails to respond to treatment despite optimum therapy with an ACE inhibitor and a beta-blocker. They may include: an aldosterone antagonist licensed to handle heart failure patients and an angiotensin II receptor antagonist (ARB) licensed for heart failure.

Clinical trials about rehabilitation should involve a supervised exercise-based rehabilitation program designed for patients with heart failure in groups. While at it, it is advisable to ensure the patient is stable and does not have a condition or device that would immaturely conclude the rehabilitation program.

During the program, you could also include a psychological and or educational component. The program may be incorporated within an existing exercise-based or other cardiac rehabilitation program.

“It should be noted patients with chronic heart failure require monitoring. This monitoring should include; a clinical assessment of functional capacity, fluid status, cardiac rhythm, nutritional status, cognitive status and a review of medication; including need for changes and possible side effects, serum urea, electrolytes, and creatinine. Also, when a patient is admitted to hospital because of heart failure, the professional should seek advice on their management plan from a specialist in heart failure,” Petersen S, Rayner M, and Wolstenholme J. (2002).

Lastly, patients with this kind of heart condition should generally be discharged from hospital only when their clinical condition is stable and the management plan is optimized. The timing should take into account patient and career wishes, and the level of community care and support.

integrative addiction conference 2015

Dr. Dalal Akoury, M.D., M.P.H. is a family physician with a wealth of knowledge and years of experience in integrative medicine. She will highly be of assistance.

Also, don’t miss an opportunity to learn and interact with professionals during this year’s Integrative Addiction Conference 2015. For more information, visit http://www.integrativeaddiction2015.com. The conference will also deliver unique approaches to telling symptoms of addiction and how to assist patients of addiction.

Clinical Trials For Heart Failure